Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för gsk2981278. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2024-03-05

Discovery of RORγ Allosteric Fluorescent Probes and Their Application: Fluorescence Polarization, Screening, and Bioimaging.

Yu YC, Tong ZJ, Liang XT, Wu JZ, Xu YJ, Wang JJ, Zhang MY, Wei TH, Yang J, Wang YB, Wang QX, Li QQ, Wang Z, Leng X, Ding N, Xue X, Sun SL, Li NG, Wang XL.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.4c00058

Bibliografisk träff 2024-02-24

Small-molecule agents for treating skin diseases.

Cai H, Wen H, Li J, Lu L, Zhao W, Jiang X, Bai R.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2024.116269

Bibliografisk träff 2023-05-12

Discovery, Synthesis, and In Vitro Characterization of 2,3 Derivatives of 4,5,6,7-Tetrahydro-Benzothiophene as Potent Modulators of Retinoic Acid Receptor-Related Orphan Receptor γt.

Fouda A, Negi S, Zaremba O, Gaidar RS, Moroz YS, Rusanov E, Paraskevas S, Tchervenkov J.

J Med Chem · research-article; journal article · DOI 10.1021/acs.jmedchem.3c00021

Bibliografisk träff 2021-12-25

Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists.

Chen L, Su M, Wu XZ, Wang DZ, Kang YY, Wang CG, Assani I, Wang MX, Zhao SF, Lv SM, Wang JW, Sun B, Li Y, Jin Q, Huang RZ, Liao ZX.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2021.114065

Bibliografisk träff 2021-11-01

Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.

Chen L, Su M, Jin Q, Wang W, Wang CG, Assani I, Wang MX, Zhao SF, Lv SM, Wang JW, Sun B, Li Y, Liao ZX.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.1c01436

Bibliografisk träff 2020-09-23

Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.

Mäder P, Kattner L.

J Med Chem · journal article · DOI 10.1021/acs.jmedchem.0c00960

Bibliografisk träff 2018-07-30

Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses.

Pandya VB, Kumar S, Sachchidanand, Sharma R, Desai RC.

J Med Chem · review; journal article · DOI 10.1021/acs.jmedchem.8b00588

Bibliografisk träff 2018-03-17

Sulfoximines as potent RORγ inverse agonists.

Ouvry G, Bihl F, Bouix-Peter C, Christin O, Defoin-Platel C, Deret S, Feret C, Froude D, Hacini-Rachinel F, Harris CS, Hervouet C, Lafitte G, Luzy AP, Musicki B, Orfila D, Parnet V, Pascau C, Pascau J, Pierre R, Raffin C, Rossio P, Spiesse D, Taquet N, Thoreau E, Vatinel R, Vial E, Hennequin LF.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2018.03.041

Bibliografisk träff 2016-08-06

Recent progress on nuclear receptor RORγ modulators.

Cyr P, Bronner SM, Crawford JJ.

Bioorg Med Chem Lett · review; journal article · DOI 10.1016/j.bmcl.2016.08.012